Role of JRC. The JRC will be responsible for (i) the overall management of the Research Program, and for approving changes and updates to the Research Plan, (ii) the monitoring, reviewing and recording of the progress of the Research Program, (iii) setting, and monitoring the spending against, the budget for Research Program Costs, as set forth in the Research Plan, (iv) facilitating the prosecution of the Product Specific Patents in accordance with Article 9 below. In addition, the JRC will provide a forum for discussion and review of BMS’ key Development activities with respect to the Compounds as set forth in the Development Plan and in updates to the Development Plan. As needed, the JRC shall establish subcommittees and working groups that will report to the JRC to further the objectives of the Research Program.
Role of JRC. The JRC will be responsible for (i) the overall management of the Preclinical Development Program, and for approving changes and updates to the Preclinical Plan, (ii) the monitoring, reviewing and recording of the progress of the Preclinical Development Program, (iii) setting, and monitoring the spending against the Budget for Preclinical Development Program Costs, as set forth in the Preclinical Plan, and (iv) facilitating the prosecution of the Product Specific Patents in accordance with Article 9 below. As needed, the JRC shall establish subcommittees and working groups that will report to the JRC to further the objectives of the Preclinical Development Program.
Role of JRC. The JRC will be responsible for (i) the overall management of the Research Program, and for approving changes and updates to the Research Plan (as set forth in Section 3.3), (ii) the monitoring, reviewing and recording of the progress of the Research Program, (iii) setting, and monitoring the spending against, the Budget for Research Program Costs (as set forth in Section 3.4), (iv) selecting Compounds to be made and tested in the conduct of the Research Program and (v) facilitating during the Research Term the prosecution of the Product Specific Patents in accordance with Article 9 below. As needed, the JRC shall establish subcommittees and working groups that will report to the JRC to further the objectives of the Research Program.
Role of JRC. The JRC will be responsible for (i) the overall management of the Research Programs, and for approving amendments to the Research Plan (as set forth in Section 3.4), (ii) the monitoring, reviewing and assessing the progress of the Research Programs, (iii) setting, and monitoring the spending against, the Budget for Research Programs costs, (iv) evaluating and determining whether a Compound delivered by Ambrx has met the PCC Criteria for a Research Program, and (v) nominating the Evaluation Compounds, discussing and evaluating the performance of the Evaluation Compounds and designating the Initial Compound, discussing and evaluating the Initial Research Program, a New Program or Replacement Program and approving and adopting appropriate amendments of the Research Plan for such New Program or Replacement Program. As needed, the JRC shall establish subcommittees and working groups that will report to the JRC to further the objectives of the Research Programs.
Role of JRC. The JRC will be responsible for (i) the overall management of the Preclinical Development Program, and for approving changes and updates to the Preclinical Plan, (ii) the monitoring, reviewing and recording of the progress of the Preclinical Development Program, (iii) ***Certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. setting, and monitoring the spending against the Budget for Preclinical Development Program Costs, as set forth in the Preclinical Plan, and (iv) facilitating the prosecution of the Product Specific Patents in accordance with Article 9 below. As needed, the JRC shall establish subcommittees and working groups that will report to the JRC to further the objectives of the Preclinical Development Program.
Role of JRC. The JRC will be responsible for:
Role of JRC. The JRC’s role as a forum for exchanging information shall consist of (a) conferring regularly regarding Licensor Know-How relating to Compounds or Follow-On Compounds, (b) conferring regularly regarding the status of preclinical testing of Follow-On Compounds, (c) reviewing data regarding Follow-On Compounds, and considering and advising on any technical issues that arise with respect to Follow-On Compounds and (d) addressing such other matters relating to Licensor’s provision of Follow-On Compounds pursuant to Section 3.6 and Merck’s testing thereof as either Party may bring before the JRC. The JRC shall not have any supervisory or decision making authority. Licensor shall use Commercially Reasonable Efforts to incorporate guidance provided by Merck’s JRC representatives regarding the desired properties of Follow-On Compounds in synthesizing or otherwise identifying Follow-On Compounds to be delivered by Licensor pursuant to Section 3.6 after such time as Licensor receives such guidance.
Role of JRC. The JRC shall meet regularly as determined by the JJESC to evaluate jobs referred to it by the JJESC. Two (2) members or alternates representing each party must be present for evaluations to be conducted. The members of the committee will participate in training as mandated by the JJESC, apply the JE system and document results, and seek clarification from incumbents and their immediate Supervisors where there is insufficient information to agree on the rating of a job, using a consistent and fair procedure. All rating decisions will be made by consensus, that is, all members must be able to live with and defend rating decisions. Any failure to reach consensus will be referred to the JJESC.
